| Attribute | Value | [1]
|----------|-------|
| Symbol | RPL8 |
| Name | Ribosomal Protein L8 |
| Chromosome | 8q24.3 |
| NCBI Gene ID | 6136 |
| UniProt ID | P62917 |
| Ensembl ID | ENSG00000126267 |
| Gene Type | Protein-coding |
| Aliases | L8, SA-1, RL8 |
RPL8 (Ribosomal Protein L8) encodes a component of the large 60S ribosomal subunit. While ribosomal proteins were historically considered mere structural components of the translation machinery, recent research has revealed that RPL8, like many other ribosomal proteins, participates in diverse cellular processes beyond canonical protein synthesis. RPL8 has been implicated in the pathogenesis of several neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD), where ribosomal dysfunction is increasingly recognized as a key pathological feature.
The ribosomal protein L8 is highly conserved across species and is essential for cell viability. Its expression is altered in various disease states, making it a potential biomarker and therapeutic target. Within the brain, RPL8 is expressed in regions critical for learning and memory, including the hippocampus, cortex, and cerebellum, as well as in the substantia nigra, which is particularly vulnerable in Parkinson's disease.
RPL8 encodes Ribosomal Protein L8, a component of the large (60S) ribosomal subunit. The protein is located in the cytoplasm and plays a critical role in protein synthesis by forming part of the peptidyl transferase center (PTC) within the ribosome. As a ribosomal protein, RPL8 contributes to the structural integrity of the ribosome and participates in the catalysis of peptide bond formation during translation.
The ribosomal machinery is essential for all cellular protein synthesis. Ribosomes consist of two subunits: the small 40S subunit handles mRNA reading, while the large 60S subunit catalyzes peptide bond formation. RPL8 is one of approximately 47 proteins that comprise the eukaryotic 60S subunit, working in concert with rRNA molecules to maintain ribosomal function.
RPL8 is positioned in the GTPase center region of the 60S ribosomal subunit, where it interacts with various translation factors. The protein contains an N-terminal domain that extends into the peptidyl transferase center and a C-terminal domain that participates in inter-subunit bridge formation. These structural features allow RPL8 to facilitate communication between the ribosomal subunits during the translation cycle.
Beyond its canonical role in translation, RPL8 has been implicated in several extra-ribosomal functions:
Gene Expression Regulation: RPL8 can function as a transcription factor, binding to specific DNA sequences and modulating the expression of genes involved in cell survival and stress responses.
Cell Cycle Control: Studies have shown that RPL8 interacts with cell cycle regulators and can influence cell proliferation in various cell types.
Apoptosis Regulation: RPL8 has been reported to interact with key apoptotic proteins, including p53, suggesting a role in programmed cell death decisions.
Stress Response: RPL8 participates in cellular stress responses, including oxidative stress and endoplasmic reticulum stress, which are relevant to neurodegeneration.
Ribosome-Associated Quality Control: RPL8 contributes to the monitoring of translational fidelity and the degradation of erroneous proteins, which is essential for neuronal homeostasis.
RPL8 is ubiquitously expressed throughout the body, including all brain regions. In the brain, expression is particularly high in:
Within neurons, RPL8 is expressed in:
Ribosomal dysfunction has emerged as a significant contributor to Alzheimer's disease (AD) pathogenesis. Multiple studies have documented reduced ribosomal RNA and protein levels in AD brain tissue, particularly in the hippocampus and cerebral cortex—regions most vulnerable to neurodegeneration. The impairment of ribosomal function leads to:
Specific mechanisms linking RPL8 to AD include:
In Parkinson's disease (PD), ribosomal abnormalities contribute to dopaminergic neuron vulnerability. The progressive loss of dopaminergic neurons in the substantia nigra pars compacta is associated with impaired protein quality control mechanisms. Key connections include:
RPL8 alterations have been documented in:
RPL8 interacts with numerous ribosomal and non-ribosomal proteins:
| Interactor | Function |
|---|---|
| RPL5 | 60S subunit assembly |
| RPL11 | 60S subunit assembly, ribosome biogenesis |
| RPL23 | Ribosomal stability |
| RPL3 | Peptidyl transferase activity |
| eEF-1α | Translation elongation |
| eEF-2 | Translation elongation |
Modulating ribosomal function represents a potential therapeutic approach for neurodegenerative diseases:
While RPL8 is not a major disease-causing gene in neurodegeneration, several polymorphisms and variants have been studied:
Key areas of ongoing research include:
Alterations in ribosomal protein expression, including RPL8, may serve as biomarkers for neurodegenerative disease progression:
While RPL8 itself is not a high-penetrance neurodegeneration gene, ribosomal protein genes collectively show: